Influenza, commonly called the flu, is a contagious respiratory infection caused by influenza viruses that attack the nose, throat, and lungs. It is not the same illness as the “stomach flu” or a bad cold. Each year in the United States alone, seasonal flu generates an estimated economic burden of roughly $11 billion and sends hundreds of thousands of people to the hospital. Understanding what the virus actually does, how it moves between people, and what works against it gives you a much better shot at managing it when it shows up.
The Virus Behind the Illness
Three types of influenza virus cause disease in humans: A, B, and C. Influenza A is the most significant. It circulates in birds and several other animals as well as humans, and it is the only type responsible for pandemics. Its outer surface carries two key proteins, hemagglutinin (HA) and neuraminidase (NA), which the virus uses to latch onto your cells and then break free to infect new ones.1PubMed Central. Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding These surface proteins come in many versions, which is why you hear labels like H1N1 or H3N2. Each combination behaves somewhat differently, and your immune system has to learn to recognize each one.
Influenza B also causes seasonal outbreaks and can make you just as sick as type A, but it circulates almost exclusively in humans and does not produce the dramatic subtype shifts that spark pandemics. Influenza C tends to cause milder illness and is far less common. For practical purposes, when doctors and public health agencies talk about “the flu,” they mean influenza A and B.
What the Flu Feels Like
Flu symptoms tend to hit fast. One day you feel fine; a few hours later you have a high fever, aching muscles, a headache, and deep fatigue. A dry cough, sore throat, and nasal congestion usually follow.2PubMed Central. A Narrative Review of Influenza: A Seasonal and Pandemic Disease That abrupt onset is one of the easiest ways to tell the flu apart from a common cold, which builds gradually over a couple of days and centers on congestion and a runny nose rather than body-wide misery.
Most healthy adults feel significantly better within a week, though a lingering cough and fatigue can drag on for two weeks or more. Children sometimes develop nausea and vomiting alongside the respiratory symptoms, which is one reason people confuse flu with gastrointestinal illness. In adults, gut symptoms are less common and, when they appear, tend to be mild.
Behind the scenes, much of what makes you feel terrible is your own immune response. Your body releases a flood of inflammatory signaling molecules to fight the virus. Research on seasonal flu patients found that levels of several of these molecules, including IL-6 and TNF-α in influenza A patients and a wider set of signals including interferon-gamma in influenza B patients, rise significantly compared to healthy controls.3PubMed Central. Clinical aspects and cytokine response in adults with seasonal influenza infection That immune storm is what produces fever, muscle pain, and fatigue. The virus itself does damage too, but the inflammatory cascade is responsible for a large share of the misery.
How the Flu Moves Between People
Flu spreads through three main routes: direct contact with a sick person or a contaminated surface, large respiratory droplets expelled when someone coughs or sneezes, and fine aerosol particles that can hang in the air and travel farther.4PubMed Central. Aerosol transmission is an important mode of influenza A virus spread For years, public health messaging focused mainly on droplets and hand hygiene, but research has made it clear that the aerosol route matters more than was once appreciated. Tiny virus-laden particles can drift across a room, which explains why flu can spread in well-ventilated spaces where people are not in close face-to-face contact.
You can be contagious before you know you are sick. Adults typically start shedding virus about a day before symptoms appear and remain contagious for roughly five to seven days afterward. Children and people with weakened immune systems can shed the virus for even longer. This pre-symptomatic window is part of why flu spreads so efficiently in schools, offices, and crowded transit.
Why Flu Peaks in Winter
In temperate climates, flu follows a remarkably consistent seasonal pattern, peaking in the colder months. The reason is not simply that people huddle indoors. Research has shown that absolute humidity, the actual amount of water vapor in the air, plays a central role. When absolute humidity drops, as it does in winter, the virus survives longer on surfaces and in the air, and transmission between people becomes more efficient.5PubMed Central. Absolute humidity modulates influenza survival, transmission, and seasonality Cold, dry winter air both outdoors and inside heated buildings creates ideal conditions for the virus. In tropical regions, where humidity stays high year-round, flu activity follows different and less predictable patterns, sometimes spiking during rainy seasons.
The COVID-19 pandemic gave researchers an unintentional experiment in flu seasonality. When countries implemented lockdowns, masking mandates, and social distancing in 2020, flu cases dropped by roughly 95 to 98 percent almost overnight.6Scientific Reports. The effect of non-pharmaceutical interventions on influenza throughout the COVID-19 pandemic: an 8-year interrupted time series study That dramatic collapse confirmed just how dependent flu is on close human contact and airborne transmission. When those measures were lifted, flu bounced back, showing that the behavioral interventions were effective in the short term but could not permanently suppress the virus.
Getting Tested
If you go to a clinic with flu-like symptoms, your provider might use one of several tests. The most common is a rapid antigen test, which gives results in about 15 minutes. These tests are good at confirming flu when they come back positive, with specificity consistently above 98 percent, but they miss a lot of actual cases. A meta-analysis of rapid tests found pooled sensitivity around 54 percent for both influenza A and B, meaning they catch only about half of true infections.7PubMed. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction A negative rapid test does not rule out flu.
Newer digital immunoassay devices perform better, catching around 80 percent of influenza A cases and about 77 percent of influenza B. Molecular tests based on nucleic acid amplification, including PCR, are the gold standard, with sensitivity above 90 percent for both types. However, PCR results can take hours to come back, and the test is more expensive. Real-world data from large studies show that PCR detects about twice as many positive cases as rapid antigen tests, though the gap narrows at the start and end of flu season when viral loads tend to be higher in people who do get infected.8PubMed. Comparative study of rapid influenza antigen tests versus PCR in an influenza-like illness population: A real-world multicenter study in China
In practice, doctors often treat based on symptoms and local flu activity, especially during peak season, rather than waiting for test results. If you have classic flu symptoms during a known outbreak, your doctor may prescribe antivirals without testing at all, particularly if you fall into a high-risk category.
Treatment Options
Antiviral drugs are the main prescription tool against flu. The most widely used is oseltamivir (Tamiflu), a neuraminidase inhibitor that blocks the virus from spreading to new cells. It works best when started within 48 hours of symptom onset and can shorten illness by a day or so while reducing the risk of complications. Zanamivir (Relenza), an inhaled neuraminidase inhibitor, works by the same mechanism. A newer option, baloxavir marboxil (Xofluza), attacks the virus differently by blocking a protein the virus needs to copy its genetic material. Studies suggest baloxavir has a similar safety and effectiveness profile to the older drugs, with the added convenience of being a single-dose pill.9PubMed Central. Antiviral Drugs in Influenza
For most otherwise healthy adults, antivirals are optional. The illness will resolve on its own. But for people at higher risk of complications, including older adults, young children, pregnant women, and anyone with chronic heart, lung, or immune conditions, early antiviral treatment can be the difference between recovering at home and ending up in the hospital.
Over-the-counter medications do not fight the virus itself but can make you more comfortable. Acetaminophen (paracetamol) and ibuprofen both work well for reducing fever and easing aches, and at standard doses they are equally safe and effective for this purpose.10PubMed. Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu Aspirin is also effective in adults but should not be given to children or teenagers with flu because of the risk of a rare but serious condition called Reye’s syndrome. Beyond painkillers, staying hydrated and resting are genuinely helpful, not just grandmotherly advice.
Complications and Who Is Most Vulnerable
For most people, flu is a miserable but self-limited illness. The danger lies in complications, and the most significant one is secondary bacterial pneumonia. Once the flu virus damages the lining of your airways, bacteria that normally live harmlessly in your nose and throat can invade the lungs. This remains a major source of hospitalization and death during flu seasons.11PubMed Central. Postviral Complications: Bacterial Pneumonia Researchers are still working to identify which flu patients are most likely to develop these secondary infections, because catching them early with antibiotics can be lifesaving.
Other complications include worsening of chronic conditions like asthma or heart failure, inflammation of the heart muscle, and, in children, ear infections and febrile seizures. The groups at highest risk overlap with those who benefit most from early antiviral treatment:
- Adults 65 and older: aging immune systems mount a weaker response and recover more slowly.
- Children under 5: especially those under 2, whose immune systems are still developing.
- Pregnant women: pregnancy shifts the immune system in ways that increase vulnerability to respiratory infections.
- People with chronic illnesses: heart disease, diabetes, lung conditions, kidney disease, and immunosuppressive conditions or treatments all raise the stakes.
Even healthy young adults occasionally develop severe flu. The 2009 H1N1 pandemic disproportionately affected younger people, partly because older adults had some residual immunity from exposure to related viruses decades earlier. The point is that while risk categories are useful, flu can surprise anyone.
Why the Flu Vaccine Changes Every Year
Influenza viruses mutate constantly. Small, accumulated changes in the HA and NA surface proteins, a process called antigenic drift, allow the virus to partially evade immunity you built up from past infections or vaccinations. This is the reason a single flu shot does not protect you for life the way a measles vaccine does. Laboratories contributing to the World Health Organization’s global surveillance network monitor circulating strains year-round and select vaccine strains months ahead of each flu season to allow time for manufacturing.12PubMed Central. Models for predicting the evolution of influenza to inform vaccine strain selection
That forecasting process is imperfect. Sometimes the virus drifts in an unexpected direction between the time the vaccine is formulated and the time flu season arrives. A study of the 2024–2025 season found that dominant circulating strains of both H1N1 and H3N2 showed reduced neutralization by sera from vaccinated individuals compared to the vaccine strains, consistent with antigenic drift outpacing the vaccine update.13Oxford Academic (The Journal of Infectious Diseases). Genomic Evolution of Influenza A Virus During the 2024-2025 Season, the Johns Hopkins Health System: Antigenic Drift Reduces Serum Neutralization In seasons like this, the vaccine still offers partial protection and tends to reduce the severity of illness even when it does not prevent infection entirely.
An additional wrinkle comes from the manufacturing process itself. Most flu vaccines are grown in chicken eggs, which can introduce changes to the virus that make the vaccine a slightly less accurate match to the strain circulating in humans. Researchers have found that these egg-adapted changes can interact with a person’s immune history in complex ways, potentially affecting how well the vaccine works not just this season but in future ones as well.14PubMed. The impact of egg adaptation and immune imprinting on influenza vaccine effectiveness Cell-based and recombinant vaccines, which skip the egg step, avoid this problem and are increasingly available.
Pandemic Flu vs. Seasonal Flu
Seasonal flu is caused by strains that have been circulating in humans for years, gradually drifting. A pandemic happens when a fundamentally new influenza A virus emerges, one that most people have no immunity to. The 20th century saw three major pandemics: in 1918, 1957, and 1968. The 1957 and 1968 pandemics were caused by reassortant viruses, where an avian flu virus swapped gene segments with a human virus, producing a hybrid with a surface protein humans had never encountered.15PubMed. The origin of the 1918 pandemic influenza virus: a continuing enigma The 1918 pandemic, which killed tens of millions, remains more mysterious; its precise origin is still debated.
This gene-swapping ability is what makes influenza A uniquely dangerous among respiratory viruses. Because it infects birds, pigs, and other animals, there is always a reservoir of novel HA and NA combinations that could jump to humans. Major antigenic shifts, where the surface protein changes dramatically rather than drifting incrementally, are the triggers for pandemics.16PubMed Central. Influenza pandemics of the 20th century
Avian Flu and the Next Pandemic Threat
Highly pathogenic avian influenza, particularly H5N1, has been circulating in bird populations for decades and periodically spills over into humans, usually through direct contact with infected poultry. These cases are alarming because H5N1 kills a high proportion of the people it infects, though human-to-human transmission has so far remained extremely rare. Monitoring of people exposed to infected birds in the United States found limited evidence of transmission, but the concern persists because the virus only needs a few key mutations to become more transmissible between people.17Emerging Infectious Diseases. Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022
More recently, H5N1 has spread to dairy cattle in the United States, an unexpected host that brings the virus into closer contact with farmworkers. Several human infections linked to dairy exposure have been documented. None have led to sustained human-to-human chains, but the expanding host range keeps this virus near the top of pandemic preparedness watchlists worldwide.
The Economic Weight of Flu
Beyond its health impact, seasonal flu is expensive. An analysis estimated the average annual economic burden of influenza in the United States at about $11.2 billion, with direct medical costs around $3.2 billion and indirect costs, mainly lost productivity and missed work, accounting for the remaining $8 billion.18PubMed. Economic burden of seasonal influenza in the United States Those indirect costs are easy to overlook. When a working-age adult gets the flu, the biggest expense is usually not the doctor visit or the prescription but the days of work lost.
A systematic review focused on adults aged 18 to 64 found that indirect costs represented up to 88 percent of the total economic burden in that age group, and that hospitalizations drove up to 75 percent of the direct medical costs.19PubMed Central. The economic burden of influenza among adults aged 18 to 64: A systematic literature review These numbers matter for policy. Decision-makers sometimes undervalue flu vaccination programs for working-age adults because the hospitalization rate in this group is lower than in the elderly, but the productivity losses are enormous and largely invisible in hospital-centered accounting.
The Search for a Universal Flu Vaccine
The annual reformulation cycle is a well-known weak point in flu prevention. Researchers have been working for years on a universal influenza vaccine, one that would target parts of the virus that stay the same across strains and subtypes, rather than the rapidly mutating HA head that current vaccines focus on. Strategies include targeting the HA stem region, which is more conserved, as well as internal viral proteins like M1 and the outer portion of the M2 protein. Delivery platforms under development range from messenger RNA constructs to virus-like particles that mimic the virus’s shape without containing its genetic material.20Animal Diseases. Development of universal influenza vaccines: strategies for broadly cross-reactive influenza vaccine responses
A truly universal vaccine would not just spare people the inconvenience of an annual shot. It could provide a standing defense against pandemic strains before they emerge, because the conserved targets are shared across avian, swine, and human influenza A viruses. Several candidates are in clinical trials, and some early results look promising, but no universal flu vaccine has yet reached the market. The complexity of the immune response to influenza, especially the tendency for the immune system to default to memories of past strains rather than respond to new ones, is one of the biggest hurdles researchers are trying to clear.